Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Hypertension. 2018 Mar 26;71(5):804–810. doi: 10.1161/HYPERTENSIONAHA.118.10266

Figure 2.

Figure 2

Potential roles of ADAM17 activation in cardiovascular pathophysiology. In addition to EGFR transactivation, ADAM17 may contribute to endothelial dysfunction and insulin resistance by producing TNFα and inhibiting ACE2.